nach oben

Neurological Sciences

Erschienen in:

30.07.2021 | COVID-19 | COVID-19 Zur Zeit gratis

Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

verfasst von: Ahmed Serkan Emekli, Asuman Parlak, Nejla Yılmaz Göcen, Murat Kürtüncü

Erschienen in: Neurological Sciences | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

The coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread rapidly all over the world. Besides severe pneumonia, it causes multisystemic disease, including neurological findings. Here, we present a patient with anti–glutamic acid decarboxylase (anti-GAD) antibody-associated cerebellitis developed after COVID-19 infection. The patient responded well to the immune treatments. Our knowledge about SARS-CoV-2 infection–related neurological disorders is limited. New data are needed to recognize the clinical spectrum of autoimmune neurological disorders that emerges after SARS-CoV-2 infection.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324:782–793CrossRef

Mitoma H, Manto M, Hampe CS (2018) Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol 17:33–58CrossRef

Manto M, Mitoma H, Hampe CS (2019) Anti-GAD antibodies and the cerebellum: where do we stand? Cerebellum 18:153–156CrossRef

Oosthuizen K, Steyn EC, Tucker L, Ncube IV, Hardie D, Marais S (2021) SARS-CoV-2 encephalitis presenting as a clinical cerebellar syndrome: a case report. Neurology. (Online ahead of print). https://doi.org/10.1212/WNL.0000000000012051.

Saha B, Saha S, Chong WH (2021) 78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19. BMJ Case Rep. 14:e243165.

Sarigecili E, Arslan I, Ucar HK, Celik U (2021) Pediatric anti-NMDA receptor encephalitis associated with COVID-19. Child’s Nerv Syst. 1–4 (Online ahead of print). doi: https://doi.org/10.1007/s00381-021-05155-2.

Werner J, Reichen I, Huber M, Abela IA, Weller M, Jelcic I (2021) Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report. BMC Infect Dis 21:1–7CrossRef

Sharma S, Ruparelia J, Bhaskar S, Tiwari S, Nag VL, Panda S (2021) Acute fulminant cerebellitis in children with COVID-19 infection: a rare but treatable complication. Pediatr Neurol 119:45–47CrossRef

Fernandes J, Puhlmann P (2021) Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2. J Neurovirol. 2–4 (Online ahead of print). doi: https://doi.org/10.1007/s13365-021-00974-0.

10.

Sanguinetti SY, Ramdhani RA (2021) Opsoclonus-myoclonus-ataxia syndrome related to the novel coronavirus (COVID-19). J Neuro-Ophthalmology (Online ahead of print). doi: https://doi.org/10.1097/WNO.0000000000001129.

11.

Urrea-Mendoza E, Okafor K, Ravindran S, Absher J, Chaubal V, Revilla FJ (2021) Opsoclonus-myoclonus-ataxia syndrome (Omas) associated with sars-cov-2 infection: post-infectious neurological complication with benign prognosis. Tremor and Other Hyperkinetic Movements 11:1–4CrossRef

12.

Chan JL, Murphy KA, Sarna JR (2021) Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J. Neurol. 1–32 (Online ahead of print). doi: https://doi.org/10.1007/s00415-021-10458-0.

13.

Foucard C, San-Galli A, Tarrano C, Chaumont H, Lannuzel A, Roze E (2021) Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID‐19. Eur J Neurol. 0–3 (Online ahead of print). doi: https://doi.org/10.1111/ene.14726.

14.

Shah PB, Desai SD (2021) Opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 infection. Neurology 96:33CrossRef

15.

Emamikhah M, Babadi M, Mehrabani M, Jalili M, Pouranian M, Daraie P et al (2021) Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol 27:26–34CrossRef

16.

Shetty K, Jadhav AM, Jayanthakumar R, Jamwal S, Shanubhogue T, Reddy MP et al (2021) Myoclonus-ataxia syndrome associated with COVID-19. J Mov Disord 14:153–156CrossRef

17.

Grimaldi S, Lagarde S, Harlé JR, Boucraut J, Guedj E (2020) Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18F-FDG PET imaging and neuronal autoantibodies. J Nucl Med 61:1726–1729CrossRef

18.

Povlow A, Auerbach AJ (2021) Acute cerebellar ataxia in COVID-19 infection: a case report. J Emerg Med 60:73–76CrossRef

19.

Wright D, Rowley R, Halks-Wellstead P, Anderson T, Wu TY (2020) Abnormal saccadic oscillations associated with severe acute respiratory syndrome coronavirus 2 encephalopathy and ataxia. Mov Disord Clin Pract 7:980–982CrossRef

20.

de Marcaida JA, Lahrmann J, Machado D, Bluth L, Dagostine M, Moro-de Casillas M et al (2020) Clinical characteristics of coronavirus disease 2019 (COVID-19) among patients at a movement disorders center. Geriatr 5:54CrossRef

21.

Dijkstra F, Van den Bossche T, Willekens B, Cras P, Crosiers D (2020) Myoclonus and cerebellar ataxia following COVID-19. Mov Disord Clin Pract 7:974–976CrossRef

22.

Schellekens MMI, Bleeker-Rovers CP, Keurlings PAJ, Mummery CJ, Bloem BR (2020) Reversible myoclonus-ataxia as a postinfectious manifestation of COVID-19. Mov Disord Clin Pract 7:977–979CrossRef

23.

Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P et al (2020) COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol 27:2651–2657CrossRef

24.

Diezma-Martín AM, Morales-Casado MI, García Alvarado N, Vadillo Bermejo A, López-Ariztegui N, Sepúlveda Berrocal MA (2020) Tremor and ataxia in COVID-19. Neurologia (Engl Ed) 35:409–410CrossRef

25.

Fadakar N, Ghaemmaghami S, Masoompour SM, Shirazi Yeganeh B, Akbari A, Hooshmandi S et al (2020) A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. Cerebellum 19:911–914CrossRef

26.

Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre JY et al (2020) Neurological syndromes associated with anti-gad antibodies. Int J Mol Sci 21:3701CrossRef

27.

Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Sharma P et al (2020) Favipiravir use in COVID-19: Analysis of suspected adverse drug events reported in the WHO database. Infect Drug Resist 13:4427–4438CrossRef

28.

Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M et al (2020) Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report. Brain Behav Immun 87:179–181CrossRef

29.

Monti G, Giovannini G, Marudi A, Bedin R, Melegari A, Simone AM et al (2020) Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 81:18–20CrossRef

30.

Guilmot A, Maldonado Slootjes S, Sellimi A, Bronchain M, Hanseeuw B, Belkhir L et al (2021) Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 268:751–757CrossRef

31.

Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T et al (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 143:3104–3120CrossRef

Titel: Anti-GAD associated post-infectious cerebellitis after COVID-19 infection
verfasst von: Ahmed Serkan Emekli
Asuman Parlak
Nejla Yılmaz Göcen
Murat Kürtüncü
Publikationsdatum: 30.07.2021
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Neurological Sciences / Ausgabe 10/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05506-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Anti-GAD associated post-infectious cerebellitis after COVID-19 infection

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Efficacy of low-level laser therapy in nerve injury repair—a new era in therapeutic agents and regenerative treatments

Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke: a meta-analysis

A new phenotype of MT-ND6 gene mutation for Leber’s hereditary optic neuropathy

Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barré syndrome and their correlations with clinical features

New daily persistent headache after SARS-CoV-2 infection: a report of two cases

Development of a cerebellar glioblastoma at the same location of a previously stable cavernous angioma

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie